Poly-Medics,Inc.
PolyMedics Innovations (PMI) is a pioneering company specializing in synthetic skin technology and biomaterials for wound healing. With over two decades of experience, PMI develops innovative, biodegradable, and biocompatible products such as SUPRATHEL® and SUPRA SDRM®, which are used worldwide to improve wound care, especially for burns and difficult-to-heal wounds. The company is committed to advancing wound treatment through proprietary polylactide technology, clinical research, and sustainable practices, aiming to revolutionize wound healing and enhance patient outcomes globally.
Industries
Nr. of Employees
small (1-50)
Poly-Medics,Inc.
Denkendorf, Baden-Wurttemberg, Germany, Europe
Products
Synthetic absorbable epidermal membrane
A single-application, porous synthetic membrane intended as a temporary epidermal substitute for epidermal and dermal wounds and split-thickness skin graft donor sites; formulated from lactide-based copolymers and designed to be hydrolytically biodegradable.
Biodegradable dermal regeneration matrix
A porous biodegradable dermal matrix with combined microporous and larger-pore structure intended for chronic and difficult-to-heal wounds to support granulation and re-epithelialisation.
Silicone-coated contact layer
A one-sided silicone-coated contact layer intended to serve as a contact interface for wounds, applicable alone or in combination with porous polymer membranes or matrices.
Synthetic absorbable epidermal membrane
A single-application, porous synthetic membrane intended as a temporary epidermal substitute for epidermal and dermal wounds and split-thickness skin graft donor sites; formulated from lactide-based copolymers and designed to be hydrolytically biodegradable.
Biodegradable dermal regeneration matrix
A porous biodegradable dermal matrix with combined microporous and larger-pore structure intended for chronic and difficult-to-heal wounds to support granulation and re-epithelialisation.
Silicone-coated contact layer
A one-sided silicone-coated contact layer intended to serve as a contact interface for wounds, applicable alone or in combination with porous polymer membranes or matrices.
Services
Clinical education and conference engagement
Presentations, poster sessions and clinical case dissemination at international conferences to support clinical adoption and training.
Regulatory documentation and post-market reporting
Provision and maintenance of Instructions for Use (IFU), SSCPs and other regulatory documentation required for marketed medical devices.
Global sales and distribution
Commercial distribution and market presence across multiple international markets supported by local distributors and sales activities.
Clinical education and conference engagement
Presentations, poster sessions and clinical case dissemination at international conferences to support clinical adoption and training.
Regulatory documentation and post-market reporting
Provision and maintenance of Instructions for Use (IFU), SSCPs and other regulatory documentation required for marketed medical devices.
Global sales and distribution
Commercial distribution and market presence across multiple international markets supported by local distributors and sales activities.
Expertise Areas
- Synthetic biomaterials for wound healing
- Dermal matrix and membrane development
- Clinical trial management and outcomes research
- Regulatory compliance for medical devices (CE, FDA 510(k), MDR)
Key Technologies
- Polylactide-based biodegradable polymers
- Porous polymer matrices for tissue regeneration
- Hydrolytic biodegradation to CO2 and H2O
- Biodegradable membrane and dermal matrix design